GeneDx Holdings Corp. Investors: Company Investigated by the Portnoy Law Firm

Core Viewpoint - GeneDx Holdings Corp. is under investigation for possible securities fraud, with a potential class action being considered for affected investors [1][3]. Group 1: Investigation and Legal Actions - The Portnoy Law Firm has initiated an investigation into GeneDx for possible securities fraud and is encouraging investors who have incurred losses to reach out for legal assistance [1][2]. - Investors can contact attorney Lesley F. Portnoy for a complimentary case evaluation regarding their legal rights and options for recovering losses [2]. Group 2: Allegations and Impact - A report by Grizzly Research on February 5, 2025, accused GeneDx of committing widespread fraud, claiming that the company's reported growth was largely fabricated and that it exploited Medicaid and Medicare systems to inflate revenue [3]. - Following the allegations in the report, GeneDx's stock price fell by 6.7% on the same day, indicating a negative market reaction to the serious claims made [4].